Skip to main content
. 2023 Aug 4;11:e15752. doi: 10.7717/peerj.15752

Table 2. Comparison of clinical features between rupture and non-rupture AAA patients.

Variables Rupture AAA (n = 32) Non-rupture AAA (n = 305) P
Diameter (cm) 6.58 ± 2.04 4.63 ± 1.61 <0.001
HbA1c (%) 6.00 ± 0.61 6.08 ± 0.90 0.672
LVEF (%) 61.10 ± 6.71 59.01 ± 10.29 0.130
cTnI (ng/ml) 0.824 ± 3.50 1.23 ± 5.28 0.683
BNP (pg/ml) 460.69 ± 1,064.06 354.85 ± 823.96 0.515
hsCRP (mg/ml) 91.11 ± 71.42 46.66 ± 62.28 0.001
Creatinine (mg/dL) 161.02 ± 79.34 117.42 ± 110.29 0.033
D-dimer (mg/L) 5.63 ± 6.02 3.81 ± 4.46 0.149
HDL-c (mmol/L) 0.88 ± 0.25 1.14 ± 0.36 <0.001
LDL-c (mmol/L) 1.99 ± 0.70 2.51 ± 0.94 0.005
TG (mmol/L) 1.62 ± 1.10 1.55 ± 1.32 0.776
TC (mmol/L) 3.67 ± 1.05 4.43 ± 1.25 0.002
ApoA1 (g/L) 0.77 ± 0.17 0.97 ± 0.23 <0.001
ApoB1 (g/L) 0.67 ± 0.20 0.80 ± 0.25 0.009
ApoB/ApoA1 0.90 ± 0.30 0.87 ± 0.50 0.761

Note:

LVEF, left ventricular ejection fraction; cTnI, cardiac troponin I; BNP, brain natriuretic peptide; hsCRP, high sensitive C reaction protein; HCY, homocysteine; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; TC, total cholesterol; ApoA1, apoliprotein A1; ApoB, apoliprotein B.